Cargando…
Oxaliplatin-induced haematological toxicity and splenomegaly in mice
PURPOSE: Haematological toxicities occur in patients receiving oxaliplatin. Mild anaemia (grade 1–2) is a common side effect and approximately 90% of recipients develop measurable spleen enlargement. Although generally asymptomatic, oxaliplatin-induced splenomegaly is independently associated with c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467301/ https://www.ncbi.nlm.nih.gov/pubmed/32877416 http://dx.doi.org/10.1371/journal.pone.0238164 |
_version_ | 1783577983173263360 |
---|---|
author | Lees, Justin G. White, Daniel Keating, Brooke A. Barkl-Luke, Mallory E. Makker, Preet G. S. Goldstein, David Moalem-Taylor, Gila |
author_facet | Lees, Justin G. White, Daniel Keating, Brooke A. Barkl-Luke, Mallory E. Makker, Preet G. S. Goldstein, David Moalem-Taylor, Gila |
author_sort | Lees, Justin G. |
collection | PubMed |
description | PURPOSE: Haematological toxicities occur in patients receiving oxaliplatin. Mild anaemia (grade 1–2) is a common side effect and approximately 90% of recipients develop measurable spleen enlargement. Although generally asymptomatic, oxaliplatin-induced splenomegaly is independently associated with complications following liver resection for colorectal liver metastasis and separately with poorer patient outcomes. Here, we investigated oxaliplatin-induced haematological toxicities and splenomegaly in mice treated with escalating dosages comparable to those prescribed to colorectal cancer patients. METHODS: Blood was analysed, and smears assessed using Wright-Giemsa staining. Paw coloration was quantified as a marker of anaemia. Spleen weight and morphology were assessed for abnormalities relating to splenomegaly and a flow cytometry and multiplex cytokine array assessment was performed on splenocytes. The liver was assessed for sinusoidal obstructive syndrome. RESULTS: Blood analysis showed dose dependent decreases in white and red blood cell counts, and significant changes in haematological indices. Front and hind paws exhibited dose dependent and dramatic discoloration indicative of anaemia. Spleen weight was significantly increased indicating splenomegaly, and red pulp tissue exhibited substantial dysplasia. Cytokines and chemokines within the spleen were significantly affected with temporal upregulation of IL-6, IL-1α and G-CSF and downregulation of IL-1β, IL-12p40, MIP-1β, IL-2 and RANTES. Flow cytometric analysis demonstrated alterations in splenocyte populations, including a significant reduction in CD45+ cells. Histological staining of the liver showed no evidence of sinusoidal obstructive syndrome but there were signs suggestive of extramedullary haematopoiesis. CONCLUSION: Chronic oxaliplatin treatment dose dependently induced haematological toxicity and splenomegaly characterised by numerous physiological and morphological changes, which occurred independently of sinusoidal obstructive syndrome. |
format | Online Article Text |
id | pubmed-7467301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-74673012020-09-11 Oxaliplatin-induced haematological toxicity and splenomegaly in mice Lees, Justin G. White, Daniel Keating, Brooke A. Barkl-Luke, Mallory E. Makker, Preet G. S. Goldstein, David Moalem-Taylor, Gila PLoS One Research Article PURPOSE: Haematological toxicities occur in patients receiving oxaliplatin. Mild anaemia (grade 1–2) is a common side effect and approximately 90% of recipients develop measurable spleen enlargement. Although generally asymptomatic, oxaliplatin-induced splenomegaly is independently associated with complications following liver resection for colorectal liver metastasis and separately with poorer patient outcomes. Here, we investigated oxaliplatin-induced haematological toxicities and splenomegaly in mice treated with escalating dosages comparable to those prescribed to colorectal cancer patients. METHODS: Blood was analysed, and smears assessed using Wright-Giemsa staining. Paw coloration was quantified as a marker of anaemia. Spleen weight and morphology were assessed for abnormalities relating to splenomegaly and a flow cytometry and multiplex cytokine array assessment was performed on splenocytes. The liver was assessed for sinusoidal obstructive syndrome. RESULTS: Blood analysis showed dose dependent decreases in white and red blood cell counts, and significant changes in haematological indices. Front and hind paws exhibited dose dependent and dramatic discoloration indicative of anaemia. Spleen weight was significantly increased indicating splenomegaly, and red pulp tissue exhibited substantial dysplasia. Cytokines and chemokines within the spleen were significantly affected with temporal upregulation of IL-6, IL-1α and G-CSF and downregulation of IL-1β, IL-12p40, MIP-1β, IL-2 and RANTES. Flow cytometric analysis demonstrated alterations in splenocyte populations, including a significant reduction in CD45+ cells. Histological staining of the liver showed no evidence of sinusoidal obstructive syndrome but there were signs suggestive of extramedullary haematopoiesis. CONCLUSION: Chronic oxaliplatin treatment dose dependently induced haematological toxicity and splenomegaly characterised by numerous physiological and morphological changes, which occurred independently of sinusoidal obstructive syndrome. Public Library of Science 2020-09-02 /pmc/articles/PMC7467301/ /pubmed/32877416 http://dx.doi.org/10.1371/journal.pone.0238164 Text en © 2020 Lees et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Lees, Justin G. White, Daniel Keating, Brooke A. Barkl-Luke, Mallory E. Makker, Preet G. S. Goldstein, David Moalem-Taylor, Gila Oxaliplatin-induced haematological toxicity and splenomegaly in mice |
title | Oxaliplatin-induced haematological toxicity and splenomegaly in mice |
title_full | Oxaliplatin-induced haematological toxicity and splenomegaly in mice |
title_fullStr | Oxaliplatin-induced haematological toxicity and splenomegaly in mice |
title_full_unstemmed | Oxaliplatin-induced haematological toxicity and splenomegaly in mice |
title_short | Oxaliplatin-induced haematological toxicity and splenomegaly in mice |
title_sort | oxaliplatin-induced haematological toxicity and splenomegaly in mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467301/ https://www.ncbi.nlm.nih.gov/pubmed/32877416 http://dx.doi.org/10.1371/journal.pone.0238164 |
work_keys_str_mv | AT leesjusting oxaliplatininducedhaematologicaltoxicityandsplenomegalyinmice AT whitedaniel oxaliplatininducedhaematologicaltoxicityandsplenomegalyinmice AT keatingbrookea oxaliplatininducedhaematologicaltoxicityandsplenomegalyinmice AT barkllukemallorye oxaliplatininducedhaematologicaltoxicityandsplenomegalyinmice AT makkerpreetgs oxaliplatininducedhaematologicaltoxicityandsplenomegalyinmice AT goldsteindavid oxaliplatininducedhaematologicaltoxicityandsplenomegalyinmice AT moalemtaylorgila oxaliplatininducedhaematologicaltoxicityandsplenomegalyinmice |